PubMed:26744332 / 559-948
Annnotations
PubTator4TogoVar
| Id | Subject | Object | Predicate | Lexical cue | proteinmutation |
|---|---|---|---|---|---|
| 26744332_2 | 246-252 | ProteinMutation | denotes | G2019S | rs34637584 |
| 26744332_5 | 256-262 | ProteinMutation | denotes | R1441C | rs33939927 |
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T77 | 25-33 | SO:0000001 | denotes | sequence |
| T82 | 135-154 | D010300 | denotes | Parkinson's disease |
| T83 | 135-154 | D010300 | denotes | Parkinson's disease |
| T86 | 174-179 | PR:Q5S006 | denotes | LRRK2 |
| T87 | 174-179 | PR:000003033 | denotes | LRRK2 |
| T88 | 174-179 | PR:Q5S007 | denotes | LRRK2 |
| T89 | 180-211 | SO:0000153 | denotes | bacterial artificial chromosome |
| T90 | 190-200 | 32630 | denotes | artificial |
| T91 | 201-211 | GO:0005694 | denotes | chromosome |
| T93 | 212-222 | SO:0000781 | denotes | transgenic |
| T94 | 212-227 | D055647 | denotes | transgenic rats |
| T98 | 274-283 | SO:0000817 | denotes | wild-type |
| T99 | 284-289 | PR:Q5S006 | denotes | LRRK2 |
| T100 | 284-289 | PR:000003033 | denotes | LRRK2 |
| T101 | 284-289 | PR:Q5S007 | denotes | LRRK2 |
| T102 | 309-314 | D006801 | denotes | human |
| T103 | 315-320 | PR:Q5S006 | denotes | LRRK2 |
| T104 | 315-320 | PR:000003033 | denotes | LRRK2 |
| T105 | 315-320 | PR:Q5S007 | denotes | LRRK2 |
| T106 | 357-365 | SO:0000167 | denotes | promoter |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-389 | DRI_Challenge | denotes | To better understand the sequence of events that lead to progressive neurophysiological deficits in vulnerable neurons and circuits in Parkinson's disease, we have generated LRRK2 bacterial artificial chromosome transgenic rats expressing either G2019S or R1441C mutant, or wild-type LRRK2, from the complete human LRRK2 genomic locus, including endogenous promoter and regulatory regions. |